We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PHGE market cap is 17.65M. The company's latest EPS is USD -0.5691 and P/E is -0.67.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.55M | -5.56M | -6.21M | -6.07M | -7.8M |
| Net Income | -6.78M | -5.89M | -6.36M | -6.41M | -7.91M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -22.21M | -30.26M | -35.46M | -27.22M | -25.35M |
| Net Income | -20.56M | -30.09M | -36.23M | -28.32M | -26.17M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 51.9M | 45.53M | 41.41M | 41.25M | 33.06M |
| Total Liabilities | 25.34M | 24.49M | 25.26M | 25.39M | 24.9M |
| Total Equity | 26.56M | 21.04M | 16.15M | 15.87M | 8.15M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 92.12M | 70.36M | 77.99M | 45.53M | 25.03M |
| Total Liabilities | 7.67M | 12.89M | 30.46M | 24.49M | 21.95M |
| Total Equity | 84.46M | 57.47M | 47.54M | 21.04M | 3.08M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.92M | -29.09M | -5.05M | -9.12M | -15.04M |
| Investing | -3.58M | -2.11M | 1.99M | 1.99M | 1.96M |
| Financing | 292k | 292k | 1.05M | 5.53M | 4.22M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -17.58M | -24.45M | -27.57M | -29.09M | -21.29M |
| Investing | 19.74M | -10.86M | 16.17M | -2.11M | 1.95M |
| Financing | 61.55M | 134k | 37.28M | 292k | 2.9M |
| Market Cap | 17.65M |
| Price to Earnings Ratio | -0.67 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.17 |
| Price to Book Ratio | 5.67 |
| Dividend Yield | - |
| Shares Outstanding | 45.98M |
| Average Volume (1 week) | 449.48k |
| Average Volume (1 Month) | 215.76k |
| 52 Week Change | 32.38% |
| 52 Week High | 0.855 |
| 52 Week Low | 0.1866 |
| Spread (Intraday) | 0.17 (34%) |
| Company Name | BiomX Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.biomx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
